Industry Symposiums

Santen

Wednesday, June 28

(13:15 – 14:15 CEST)
Auditorium

Navigating the evolving treatment paradigm: New insights to meet the diverse needs of patients with glaucoma

13:15-13:20Welcome and introductionProf. Norbert Pfeiffer (Germany)
13:20-13:35Exploring a new path taken: The latest evidence on a novel therapeutic strategy in EuropeProf. Francesco Oddone (Italy)
13:35-13:45Insights into the road less travelled: Real-life experience on the use of netarsudil/latanoprost fixed-dose combinationProf. Verena Prokosch  (Germany)
13:45-13:55At the intersection of positive patient outcomes: Can we provide consistent IOP control without compromising patients’ quality of life?Prof. Gábor Holló (Hungary)
13:55-14:10Looking at the journey ahead: A long-term outlook on the effectiveness and safety of ab externo LIGSProf. Julián García Feijóo (Spain)
14:10-14:15Summary and closing remarksProf. Norbert Pfeiffer (Germany)
Abbvie

Thursday, June 29

(7:30 – 8:30 CEST)

Room A

Viatris

Thursday, June 29

(7:30 – 8:30 CEST)

Room B

Innovations in Glaucoma Treatment: The Legacy and Future
Perspectives

07:30-07:35Welcome and introductionProf. Stefano Gandolfi (Italy)
07:35-07:55A Lasting Legacy: Ensuring The Future Of Glaucoma ManagementProf. Catherine Birt (United Kingdom)
07:55-08:15Optimizing Glaucoma Management: From Research to Clinical PracticeProf. Francesca Cordeiro (United Kingdom)
08:15-08:25Q&A and panel discussionAll
08:25-08:30Closing remarksProf. Stefano Gandolfi (Italy)
Abbvie

Thursday, June 29
(12:15 – 13:15 CEST)
Auditorium

Tomey

Thursday, June 29

(18:00 – 19:00 CEST)

Room D

CASIA2 and its significant impact on glaucoma diagnostic

Speaker 1: Prof. Christopher Kai-shun Leung, MD
“360 degree evaluation of iris trabecular contact with anterior segment optical coherence tomography for detection of primary angle closure disease” 

Speaker 2: Felix Gonzalez-Lopez, MD, PhD
” Glaucoma and ICL Significance of the trabecular angle in posterior chamber phakic intraocular lens surgery”

ELIOS Vision

Thursday, June 29

(18:00 – 19:00 CEST)

Room E

What the hELIOS?

Moderators: Ike Ahmed & Keith Barton

18:03-18:07WelcomeKeith Barton (United Kingdom)
18:07-18:15Unmet needs in glaucoma treatmentIke Ahmed (Canada)
18:15-18:20Today and tomorrows surgical paradigmKeith Barton (United Kingdom)
18:20-18:27Adopting ELIOS: Technique & Learning curveAlice Grise-Dulac (France)
18:27-18:34Long-term experience with ELIOSAnselm Juenemann (Germany)
18:34-18:41The impact of ELIOS on disease progressionAntonio Moreno-Valladares (Spain)
18:41-18:56Q&A and discussionAll
18:56-19:00Final remarksIke Ahmed & Keith Barton
Santen

Thursday, June 29

(18:00 – 19:00 CEST)

Room B

Crossing new frontiers: Global solutions in glaucoma management

18:00-18:05Laying the foundations: Welcome and introductionProf. Ingeborg Stalmans (Belgium)
18:05-18:20Hiding in plain sight: PAPS and the clinical experience with omidenepag isopropylProf. Masaki Tanito (Japan)
18:20-18:35A tale of two pathways: Clinical and real-world insights on the use of netarsudil as monotherapy and in fixed-dose combination with latanoprostProf. Jella An (United States)
18:35-18:45The evolving surgical landscape: Contemporary approaches and practical insights into the role of ab externo LIGSProf. Ingeborg Stalmans (Belgium)
18:45-18:55Panel discussion and debateAll; chaired by Prof. Ingeborg Stalmans (Belgium)
18:55-19:00Summary and closeProf. Ingeborg Stalmans (Belgium)
VISUfarma

Thursday, June 29

(18:00 – 19:00 CEST)

Room A

CONNECTING THE DOTS IN GLAUCOMA
because there is still a lot to do…

Official opening
Welcome / General session
Dr. Alessio Martucci, MD, PhD (Italy)
Glaucoma treatment options: when laser treatment is not enoughProfessor Gus Gazzard (United Kingdom)
Optimising glaucoma diagnosisMr. Andrew Tatham (United Kingdom)
Why is Neuroprotection a step not to miss?Professor Piero Barbanti (Italy)
IOP independent therapies for glaucomatous neurodegenerationProfessor Colin E. Willoughby (Ireland)
iSTAR

Thursday, June 29

(18:00 – 19:00 CEST)

Room C

From Evidence-Based Data to Clinical Practice: Safety and Efficacy of Supraciliary MIGS

18:00Advantages and opportunities of the supraciliary spaceSteve Sarkisian (Chair)
18:15Who can benefit from supraciliary MIGS? Patient selection with MINIjectKarsten Klabe
18:30Intraoperative and postoperative safety of supraciliary MIGS: Experience report after one year of MINIject implantationsFaisal Ahmed
18:45Sustainable effectiveness of MINIject: 3 year pooled data for the STAR-GLOBAL – studyInder Paul Singh
BELKIN Vision

Friday, June 30

(7:30 – 8:30 CEST)

Room C

Direct-SLT (DSLT): Welcome to the Future of Glaucoma Laser Therapy
First Feedback and Experiences in Europe

  • Prof. Gandolfi
  • Prof. Gus Gazzard
  • Prof. Burkhard Dick
  • Case presentation and Panel Discussion followed by Q&A

Moderator: Dr. Paul Singh 

Alcon

Friday, June 30

(7:30 – 8:30 CEST)

Room A

Hydrus Microstent – Your MIGS Choice Matters

Speakers: Chelvin Sng, Karsten Klabe, Leon Au

Topic:

  • Hydrus Microstent Outcomes from the HORIZON 5 year RCT & Comparative Trials
  • Hydrus Microstent Implantation Steps & Pearls
  • Hydrus Microstent – MIGS Surgeon Journey
Topcon

Friday, June 30

(7:30 – 8:30 CEST)

Room D

Using big data and advanced technology to enhance clinical decision making 

Welcome by the program Chair – Robert Weinreb, MD
Use of a large, real-world population database to develop AI tools for glaucoma Miriam Kolko, MD, PhD
Structure-function and repeatability agreement between a new, bi-field VF technology and HFA Takashi Nishida, MD, PhD
Optimization and utilization of glaucoma clinical decision support systems Jithin Yohannan, MD, MPH
Diagnostic efficacy of retinal nerve fiber layer optical texture analysis (ROTA) of Maestro2 and Triton wide-field scans Chris Leung, MD
Audience Q&A Program Chair
Concluding remarks Program Chair
iTrack Advance, 
Nova Eye Medical

Friday, June 30

(7:30 – 8:30 CEST)

Room B

Canaloplasty: Lighting the way in stent-free, tissue-sparing MIGS

Join us for a dynamic panel discussion led by Ike Ahmed, MD, FRCSC.

Faculty:
Andrew Tatham (UK)
Jose Maria Martinez de la Casa (Spain)
Neeru Vallabh (UK)
Karsten Klabe (Germany)
Ticiana de Francesco (Brazil)
Antonio Fea (Italy)
Norbert Koerber (Germany)
Karl Mercieca (Germany) 

Moderator: 
Ike Ahmed (Canada)

Abbvie

Friday, June 30
(12:15 – 13:15 CEST)
Auditorium

AbbVie Industry Sponsored Luncheon symposium for Healthcare Professionals only
Interventional glaucoma: a management approach with XEN® gel implant

Zeiss

Friday, June 30

(18:00 – 19-00 CEST)

Room C

Optimizing Care of Glaucoma Patients: From detection through intervention

Topics:
Application of the Zeiss Glaucoma workflow.
This will include discussion of OCT analysis, Visual Field indices, detecting progression using FORUM, and incorporating SLT into clinical practice.

Panel:

Moderator – Gus Guzzard, Speakers – Ryo Asaoka, Matteo Sacchi, Paul Singh

BVI

Friday, June 30

(18:00 – 19-00 CEST)

Room B

Endoscopic Cyclophotocoagulation (ECP) and Endoscopy for the Contemporary Management of Glaucoma

Professor K. Sheng Lim, St Thomas’ Hospital & King’s College London
Mr. Gokulan Ratnarajan, Queen Victoria NHS Trust, East Grinstead, UK
Robert J. Noecker, M.D., Ophthalmic consultants of Connecticut, Fairfield, CT. Yale University school of medicine, New Haven, CT, USA.
Juan Carlos Izquierdo, M.D., Clinica de Ojos OftalmoSalud, Lima, Peru

Topics Discussed:

  • ECP for the treatment of mild to moderate glaucoma in conjunction with phacoemulsification
  • Outcomes of phacoemulsification combined with two trabecular microbypass stents, with or without ECP
  • ECP and endoscopy in the management of glaucoma; angle based, complex, and novel procedures
  • Combining phacoemulsification, ab-interno trabeculectomy and ECP in Primary Open-Angle Glaucoma patients